The Latest Cardiac and Vascular News
Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand San Francisco, Calif. – December 17, 2019 – Vascular access technology pioneer Velano Vascular today announced that it has closed the second tranche of a $25 million growth financing […]
written by Ken Dropiewski, McDermott & Bull Executive Search Who and Why? Looking back at M&A activity this year, I took notice of a few that stood out, irrespective of their size. One could argue that they saw some of these coming, and others were surprising – regardless it makes […]
Company Ramps Up Commercialization of ControlRad Trace, an FDA-cleared Technology to Reduce Radiation Exposure During Fluoroscopically Guided Procedures ATLANTA–(BUSINESS WIRE)–ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced several additions to its leadership team. Joining are Peter […]
HOUSTON, Dec. 16, 2019 /PRNewswire/ — Millar, Inc., a leading manufacturer and OEM solutions provider of sensor-based devices for clinical and life science applications, is pleased to celebrate an ongoing and successful strategic worldwide partnership with ADInstruments, an industry leader of data acquisition systems. The exclusive worldwide distribution agreement originated in November 2014 with an official announcement at […]
NEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Correvio Pharma Corp. (NASDAQ: CORV) securities between October 23, […]
BOSTON–(BUSINESS WIRE)–Elucid Bioimaging Inc. is pleased to announce it has relocated its headquarters to 2 Park Plaza in downtown Boston. “This move helps facilitate Elucid’s ongoing expansion and provides increased proximity to research institutes, provider partners, and technology talent,” said CEO Blake Richards. Elucid is also pleased to announce the […]
written by Eudora Wang, Deal street Asia Chinese Heart Valve Device Maker Venus Medtech Nabs $308m in HK IPO December 10, 2019 – Venus Medtech, a Chinese company that produces heart valve replacement devices, has raised HK$2.41 billion ($308 million) in an initial public offering (IPO) on the Hong Kong […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of an inducement equity award to a newly hired employee (the “Awardee”). The award was approved by the Company’s Compensation Committee, which is comprised of independent directors, on […]
CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTC: HMTXF) is pleased to announce the appointment of David Wood to the position of Chairman, Bryson Goodwin to the position of Chief Executive Officer, Thomas Smeenk to the position of President, and […]
WEST CONSHOHOCKEN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal” or the “Company”), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, today announced the pricing of the previously-announced underwritten secondary offering by […]
